{"nct_id":"NCT06100744","title":"A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab","status":"RECRUITING","status_verified_date":"2025-07","start_date":"2024-07-08","start_date_type":"ACTUAL","primary_completion_date":"2026-09","primary_completion_date_type":"ESTIMATED","completion_date":"2028-10","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["ABBV"]}